Inhaled insulin drug Afrezza, from LA’s MannKind, is approvedLos Angeles TimesLos Angeles biotech entrepreneur Alfred Mann founded Mannkind, maker of Afrezza. (Kirk McKoy / Los Angeles Times). James Queally contact the reporter · Economy, Business and FinancePharmaceutical IndustryDiabetesMannKind CorporationFood and …FDA Approves Inhalable Diabetes Drug AfrezzaABC NewsUPDATE 2-US FDA approves MannKind’s diabetes therapy AfrezzaReutersFDA Approves MannKind’s Inhaled Insulin TreatmentWall Street JournalMarketWatch -Bloombergall 57 news articles …Read Full Story
Inhaled insulin drug Afrezza, from LA's MannKind, is approved - Los Angeles Times
Real Estate of Cebu
